Infliximab and nephrotic syndrome
- PMID: 16204273
- DOI: 10.1093/ndt/gfi180
Infliximab and nephrotic syndrome
Abstract
Infliximab is a chimeric tumor necrosis factor-alpha (TNF-alpha) monoclonal antibody, which has been used extensively in patients with rheumatoid arthritis and inflammatory bowel disease. It also appears to be effective in other conditions such as psoriasis and ankylosing spondylitis. The major side effect of infliximab is infection. Renal complications are uncommon and not well recognized. This report describes a probable case of infliximab-induced membranous nephropathy.
Similar articles
-
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.Br J Dermatol. 2007 Feb;156(2):329-36. doi: 10.1111/j.1365-2133.2006.07639.x. Br J Dermatol. 2007. PMID: 17223874
-
New development in the treatment of psoriasis--infliximab.Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):322-7. Ann Univ Mariae Curie Sklodowska Med. 2003. PMID: 15315008 Review.
-
[Infliximab].Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:7-13. Actas Dermosifiliogr. 2008. PMID: 19080986 Review. Spanish.
-
Serum sickness due to infliximab in a patient with psoriasis.J Drugs Dermatol. 2004 May-Jun;3(3):305-8. J Drugs Dermatol. 2004. PMID: 15176166
-
[Infectious risk].Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:14-22. Actas Dermosifiliogr. 2008. PMID: 19080987 Spanish.
Cited by
-
In Silico Identification of a Potential TNF-Alpha Binder Using a Structural Similarity: A Potential Drug Repurposing Approach to the Management of Alzheimer's Disease.Biomed Res Int. 2024 Jan 6;2024:9985719. doi: 10.1155/2024/9985719. eCollection 2024. Biomed Res Int. 2024. PMID: 38221912 Free PMC article.
-
Long-term remission of nephrotic syndrome with etanercept for concomitant juvenile idiopathic arthritis.Pediatr Nephrol. 2010 Oct;25(10):2175-7. doi: 10.1007/s00467-010-1571-5. Epub 2010 Jun 9. Pediatr Nephrol. 2010. PMID: 20532801
-
Kidney disease and psoriasis: novel evidences beyond old concepts.Clin Rheumatol. 2016 Feb;35(2):297-302. doi: 10.1007/s10067-015-3126-4. Epub 2015 Nov 28. Clin Rheumatol. 2016. PMID: 26615613 Review.
-
Different renal manifestations associated with very early onset pediatric inflammatory bowel disease: case report and review of literature.BMC Nephrol. 2021 Apr 22;22(1):146. doi: 10.1186/s12882-021-02358-2. BMC Nephrol. 2021. PMID: 33888087 Free PMC article. Review.
-
Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.World J Pediatr. 2015 Feb;11(1):21-8. doi: 10.1007/s12519-015-0003-9. Epub 2015 Jan 28. World J Pediatr. 2015. PMID: 25822700 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials